Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells

Differentiation

Volumn 81, Issue 1, 2011, Pages 25-34

  Buechner, Jochen ^a,b   Henriksen, Jørn R ^a,b   Haug, Bjørn Helge ^b   Tømte, Ellen ^b   Flaegstad, Trond ^a,b   Einvik, Christer ^a  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

MicroRNA; Mir 21; MYCN; Neuroblastoma; Neuronal differentiation

Indexed keywords

CALRETICULIN; CHROMOGRANIN B; MYC PROTEIN; NEUROPEPTIDE Y; TRANSCRIPTOME;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MICROARRAY ANALYSIS; NEUROBLASTOMA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE, TUMOR; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE KNOCKDOWN TECHNIQUES; GENES, MYC; HUMANS; MICROARRAY ANALYSIS; MICRORNAS; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING;

EID: 78649651523     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1016/j.diff.2010.09.184     Document Type: Article

References (58)

1. Afanasyeva E.A., Hotz-Wagenblatt A., Glatting K.H., Westermann F. New miRNAs cloned from neuroblastoma. BMC Genom. 2008, 9:52.
2. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
3. Bell E., Premkumar R., Carr J., Lu X., Lovat P.E., Kees U.R., Lunec J., Tweddle D.A. The role of MYCN in the failure of MYCN amplified neuroblastoma cell lines to G1 arrest after DNA damage. Cell Cycle 2006, 5:2639-2647.
4. Beveridge N.J., Tooney P.A., Carroll A.P., Tran N., Cairns M.J. Down-regulation of miR-17 family expression in response to retinoic acid induced neuronal differentiation. Cell Signal 2009, 21:1837-1845.
5. Bray I., Bryan K., Prenter S., Buckley P.G., Foley N.H., Murphy D.M., Alcock L., Mestdagh P., Vandesompele J., Speleman F., London W.B., McGrady P.W., Higgins D.G., O'Meara A., O'Sullivan M., Stallings R.L. Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival. PLoS ONE 2009, 4:e7850.
6. Breit S., Ashman K., Wilting J., Rossler J., Hatzi E., Fotsis T., Schweigerer L. The N-myc oncogene in human neuroblastoma cells: down-regulation of an angiogenesis inhibitor identified as activin A. Cancer Res. 2000, 60:4596-4601.
7. Brodeur G.M., Seeger R.C. Gene amplification in human neuroblastomas: basic mechanisms and clinical implications. Cancer Genet. Cytogenet. 1986, 19:101-111.
8. Cetinkaya C., Hultquist A., Su Y., Wu S., Bahram F., Pahlman S., Guzhova I., Larsson L.G. Combined IFN-gamma and retinoic acid treatment targets the N-Myc/Max/Mad1 network resulting in repression of N-Myc target genes in MYCN-amplified neuroblastoma cells. Mol. Cancer Ther. 2007, 6:2634-2641.
9. Chayka O., Corvetta D., Dews M., Caccamo A.E., Piotrowska I., Santilli G., Gibson S., Sebire N.J., Himoudi N., Hogarty M.D., Anderson J., Bettuzzi S., Thomas-Tikhonenko A., Sala A. Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas. J. Nat. Cancer Inst. 2009, 101:663-677.
10. Chen Y., Stallings R.L. Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res. 2007, 67:976-983.
11. Edsjo A., Nilsson H., Vandesompele J., Karlsson J., Pattyn F., Culp L.A., Speleman F., Pahlman S. Neuroblastoma cells with overexpressed MYCN retain their capacity to undergo neuronal differentiation. Lab Invest. 2004, 84:406-417.
12. Edsjo A., Holmquist L., Pahlman S. Neuroblastoma as an experimental model for neuronal differentiation and hypoxia-induced tumor cell dedifferentiation. Semin. Cancer Biol. 2007, 17:248-256.
13. Evangelisti C., Florian M.C., Massimi I., Dominici C., Giannini G., Galardi S., Bue M.C., Massalini S., McDowell H.P., Messi E., Gulino A., Farace M.G., Ciafre S.A. MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness. FASEB J. 2009, 23:4276-4287.
14. Folini M., Gandellini P., Longoni N., Profumo V., Callari M., Pennati M., Colecchia M., Supino R., Veneroni S., Salvioni P., Valdagni R., Daidone M.G., Zaffaroni N. miR-21: an oncomir on strike in prostate cancer. Mol. Cancer 2010, 9:12.
15. Fontana L., Fiori M.E., Albini S., Cifaldi L., Giovinazzi S., Forloni M., Boldrini R., Donfrancesco A., Federici V., Giacomini P., Peschle C., Fruci D. Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS ONE 2008, 3:e2236.
16. Frankel L.B., Christoffersen N.R., Jacobsen A., Lindow M., Krogh A., Lund A.H. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem. 2008, 283:1026-1033.
17. Fujita S., Ito T., Mizutani T., Minoguchi S., Yamamichi N., Sakurai K., Iba H. miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J. Mol. Biol. 2008, 378:492-504.
18. Fukuda, Y., Kawasaki,H., Taira, K., 2005. Exploration of human miRNA target genes in neuronal differentiation. Nucleic Acids Symposium Series (Oxford), pp. 341-342.
19. Gabriely G., Wurdinger T., Kesari S., Esau C.C., Burchard J., Linsley P.S., Krichevsky A.M. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol. Cell Biol. 2008, 28:5369-5380.
20. Haber M., Bordow S.B., Gilbert J., Madafiglio J., Kavallaris M., Marshall G.M., Mechetner E.B., Fruehauf J.P., Tee L., Cohn S.L., Salwen H., Schmidt M.L., Norris M.D. Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cells. Oncogene 1999, 18:2777-2782.
21. Hellemans J., Mortier G., De Paepe A., Speleman F., Vandesompele J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 2007, 8:R19.
22. Henriksen, J.R., Buechner, J., Løkke, C., Flǣgstad, T., Einvik, C., 2011. Inhibition of gene function in mammalian cells using short-hairpin RNA (shRNA). In: Nielsen, H. (Ed.), RNA, Methods Mol. Biol., vol. 703, in press, doi:. http://10.1007/978-1-59745-248-9_13.
23. Henriksson M., Luscher B. Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res. 1996, 68:109-182.
24. Hero B., Simon T., Spitz R., Ernestus K., Gnekow A.K., Scheel-Walter H.G., Schwabe D., Schilling F.H., Benz-Bohm G., Berthold F. Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97. J. Clin. Oncol. 2008, 26:1504-1510.
25. Houbaviy H.B., Murray M.F., Sharp P.A. Embryonic stem cell-specific MicroRNAs. Dev. Cell 2003, 5:351-358.
26. Hu H., Du L., Nagabayashi G., Seeger R.C., Gatti R.A. ATM is down-regulated by N-Myc-regulated microRNA-421. Proc. Natl. Acad. Sci. USA 2010, 107:1506-1511.
27. Judware R., Culp L.A. Concomitant down-regulation of expression of integrin subunits by N-myc in human neuroblastoma cells: differential regulation of alpha2, alpha3 and beta1. Oncogene 1997, 14:1341-1350.
28. Kasashima K., Nakamura Y., Kozu T. Altered expression profiles of microRNAs during TPA-induced differentiation of HL-60 cells. Biochem. Biophys. Res. Commun. 2004, 322:403-410.
29. Kim, Y.J., Hwang, S.J., Bae, Y.C., Jung, J.S.,miR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells 2009.
30. Krichevsky A.M., Gabriely G. miR-21: a small multi-faceted RNA. J. Cell Mol. Med. 2009, 13:39-53.
31. Lagos-Quintana M., Rauhut R., Lendeckel W., Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001, 294:853-858.
32. Landgraf P., Rusu M., Sheridan R., Sewer A., Iovino N., Aravin A., Pfeffer S., Rice A., Kamphorst A.O., Landthaler M., Lin C., Socci N.D., Hermida L., Fulci V., Chiaretti S., Foa R., Schliwka J., Fuchs U., Novosel A., Muller R.U., Schermer B., Bissels U., Inman J., Phan Q., Chien M., Weir D.B., Choksi R., De Vita G., Frezzetti D., Trompeter H.I., Hornung V., Teng G., Hartmann G., Palkovits M., Di Lauro R., Wernet P., Macino G., Rogler C.E., Nagle J.W., Ju J., Papavasiliou F.N., Benzing T., Lichter P., Tam W., Brownstein M.J., Bosio A., Borkhardt A., Russo J.J., Sander C., Zavolan M., Tuschl T. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129:1401-1414.
33. Laneve P., Di Marcotullio L., Gioia U., Fiori M.E., Ferretti E., Gulino A., Bozzoni I., Caffarelli E. The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells. Proc. Natl. Acad. Sci. USA 2007, 104:7957-7962.
34. Le M.T., Xie H., Zhou B., Chia P.H., Rizk P., Um M., Udolph G., Yang H., Lim B., Lodish H.F. MicroRNA-125b promotes neuronal differentiation in human cells by repressing multiple targets. Mol. Cell Biol. 2009, 29:5290-5305.
35. Li J., Kretzner L. The growth-inhibitory Ndrg1 gene is a Myc negative target in uman neuroblastomas and other cell types with overexpressed N- or c-myc. Mol. Cell Biochem. 2003, 250:91-105.
36. Loven J., Zinin N., Wahlstrom T., Muller I., Brodin P., Fredlund E., Ribacke U., Pivarcsi A., Pahlman S., Henriksson M. MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma. Proc. Natl. Acad. Sci. USA 2010, 107:1553-1558.
37. Maris J.M., Hogarty M.D., Bagatell R., Cohn S.L. Neuroblastoma. Lancet 2007, 369:2106-2120.
38. Meng F., Henson R., Wehbe-Janek H., Ghoshal K., Jacob S.T., Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007, 133:647-658.
39. Mestdagh P., Van Vlierberghe P., De Weer A., Muth D., Westermann F., Speleman F., Vandesompele J. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol. 2009, 10:R64.
40. Mestdagh P., Fredlund E., Pattyn F., Schulte J.H., Muth D., Vermeulen J., Kumps C., Schlierf S., De Preter K., Van Roy N., Noguera R., Laureys G., Schramm A., Eggert A., Westermann F., Speleman F., Vandesompele J. MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors. Oncogene 2010, 29:1394-1404.
41. Miska E.A., Alvarez-Saavedra E., Townsend M., Yoshii A., Sestan N., Rakic P., Constantine-Paton M., Horvitz H.R. Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol. 2004, 5:R68.
42. Negroni A., Scarpa S., Romeo A., Ferrari S., Modesti A., Raschella G. Decrease of proliferation rate and induction of differentiation by a MYCN antisense DNA oligomer in a human neuroblastoma cell line. Cell Growth Differ. 1991, 2:511-518.
43. van Noesel M.M., Versteeg R. Pediatric neuroblastomas: genetic and epigenetic 'danse macabre'. Gene 2004, 325:1-15.
44. Peukert K., Staller P., Schneider A., Carmichael G., Hanel F., Eilers M. An alternative pathway for gene regulation by Myc. EMBO J. 1997, 16:5672-5686.
45. Peverali F.A., Orioli D., Tonon L., Ciana P., Bunone G., Negri M., Della-Valle G. Retinoic acid-induced growth arrest and differentiation of neuroblastoma cells are counteracted by N-myc and enhanced by max overexpressions. Oncogene 1996, 12:457-462.
46. Schleiermacher G., Raynal V., Janoueix-Lerosey I., Combaret V., Aurias A., Delattre O. Variety and complexity of chromosome 17 translocations in neuroblastoma. Genes Chromosomes Cancer 2004, 39:143-150.
47. Schulte J.H., Horn S., Otto T., Samans B., Heukamp L.C., Eilers U.C., Krause M., Astrahantseff K., Klein-Hitpass L., Buettner R., Schramm A., Christiansen H., Eilers M., Eggert A., Berwanger B. MYCN regulates oncogenic MicroRNAs in neuroblastoma. Int. J. Cancer 2008, 122:699-704.
48. Sempere L.F., Freemantle S., Pitha-Rowe I., Moss E., Dmitrovsky E., Ambros V. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 2004, 5:R13.
49. Silber J., Lim D.A., Petritsch C., Persson A.I., Maunakea A.K., Yu M., Vandenberg S.R., Ginzinger D.G., James C.D., Costello J.F., Bergers G., Weiss W.A., Alvarez-Buylla A., Hodgson J.G. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 2008, 6:14.
50. Smirnova L., Grafe A., Seiler A., Schumacher S., Nitsch R., Wulczyn F.G. Regulation of miRNA expression during neural cell specification. Eur. J. Neurosci. 2005, 21:1469-1477.
51. Smith A.G., Popov N., Imreh M., Axelson H., Henriksson M. Expression and DNA-binding activity of MYCN/Max and Mnt/Max during induced differentiation of human neuroblastoma cells. J. Cell Biochem. 2004, 92:1282-1295.
52. Thiele C.J., Israel M.A. Regulation of N-myc expression is a critical event controlling the ability of human neuroblasts to differentiate. Exp. Cell Biol. 1988, 56:321-333.
53. Thiele C.J., Reynolds C.P., Israel M.A. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature 1985, 313:404-406.
54. Tonelli S., Purgato C., Camerin R., Fronza F., Bologna S., Alboresi M., Franzoni R., Corradini S., Sforza A., Faccini J.M., Shohet R., Marchelli, Pession A. Anti-gene peptide nucleic acid specifically inhibits MYCN expression in human neuroblastoma cells leading to cell growth inhibition and apoptosis. Mol. Cancer Ther. 2005, 4:779-786.
55. Tweddle D.A., Malcolm A.J., Bown N., Pearson A.D., Lunec J. Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line. Cancer Res. 2001, 61:8-13.
56. Wang X., Tang S., Le S.Y., Lu R., Rader J.S., Meyers C., Zheng Z.M. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS ONE 2008, 3:e2557.
57. Zhu S., Si M.L., Wu H., Mo Y.Y. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J. Biol. Chem. 2007, 282:14328-14336.
58. Zhu S., Wu H., Wu F., Nie D., Sheng S., Mo Y.Y. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 2008, 18:350-359.